Early research (Phase 1)Study completedNCT06438263What this trial is testingEvaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy ParticipantsWho this might be right forAtopic Dermatitis Amgen 231
Not applicableNot Yet RecruitingNCT07549828What this trial is testingSebum Metabolomics and Lipidomics for Clinical ApplicationsWho this might be right forAcneAtopic DermatitisSeborrheic Dermatitis+2 more National Taiwan University Hospital 200
Early research (Phase 1)Study completedNCT01850849What this trial is testingSafety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 CreamWho this might be right forAtopic Dermatitis LEO Pharma 23
Early research (Phase 1)Ended earlyNCT05382819What this trial is testingA Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic DermatitisWho this might be right forAtopic Dermatitis Eczema Fresh Tracks Therapeutics, Inc. 89
Early research (Phase 1)Study completedNCT02743871What this trial is testingStudy Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic DermatitisWho this might be right forHealthyChronic Rhinosinusitis With Nasal PolypsAtopic Dermatitis Pfizer 97
Early research (Phase 1)UnknownNCT05843422What this trial is testingA First-in-Human Study of QY211 Gel in Adult SubjectsWho this might be right forAtopic Dermatitis E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. 56
Early research (Phase 1)Study completedNCT00958516What this trial is testingAssessment of the Phototoxic Potential of LEO 29102 CreamWho this might be right forAtopic Dermatitis LEO Pharma 32
Early research (Phase 1)Study completedNCT03514511What this trial is testingSafety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic DermatitisWho this might be right forAtopic Dermatitis LEO Pharma 47
Very early researchStudy completedNCT02343783What this trial is testingEvaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy ParticipantsWho this might be right forDermatitis, AtopicAsthmaHealthy Janssen Research & Development, LLC 46
Early research (Phase 1)Ended earlyNCT04211415What this trial is testingPhase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic DermatitisWho this might be right forAtopic Dermatitis Daiichi Sankyo Co., Ltd. 8
Early research (Phase 1)Ended earlyNCT03846466What this trial is testingStudy of KHK 4323 in Healthy Volunteers and Subjects With Atopic DermatitisWho this might be right forAtopic Dermatitis Kyowa Kirin Co., Ltd. 5
Early research (Phase 1)Study completedNCT07264335What this trial is testingA Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy SubjectsWho this might be right forAtopic Dermatitis Guangdong Hengrui Pharmaceutical Co., Ltd 160
Early research (Phase 1)Study completedNCT03260595What this trial is testingCrisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic DermatitisWho this might be right forHealthyAtopic Dermatitis Pfizer 32
Early research (Phase 1)UnknownNCT05215808What this trial is testingSAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis SubjectsWho this might be right forAtopic Dermatitis Ribon Therapeutics, Inc. 72
Early research (Phase 1)Study completedNCT01614756What this trial is testingA Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic DermatitisWho this might be right forHealthy Subjects and Atopic Dermatitis Subjects Bristol-Myers Squibb 93
Not applicableStudy completedNCT02125695What this trial is testingPilot Tape Harvesting StudyWho this might be right forAtopic DermatitisHealthyDiscoid Lupus Erythematosus+1 more Biogen 37
Early research (Phase 1)Study completedNCT04544943What this trial is testingSafety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic DermatitisWho this might be right forAtopic Dermatitis Hoth Therapeutics, Inc. 31
Early research (Phase 1)Study completedNCT05170243What this trial is testingA Clinical Study in Healthy Subjects to Evaluate 9MW1911 InjectionWho this might be right forAsthmaCOPDAtopic Dermatitis Mabwell (Shanghai) Bioscience Co., Ltd. 28
Not applicableStudy completedNCT05048121What this trial is testingRCT to Evaluate the Cosmetic Efficacy of Demo-cosmetic Active Ingredient CLS02021Who this might be right forOverall Skin AppearanceDry Skin; Eczema Anbiome Labs LLC 50
Early research (Phase 1)Study completedNCT02590289What this trial is testingA Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult SubjectsWho this might be right forDermatitis, Atopic Fresh Tracks Therapeutics, Inc. 20